Palliative Behandlung von Patienten mit fortgeschrittenem Pankreaskarzinom

Zusammenfassung

Integrative onkologische Therapiekonzepte sind eine Kombination aus konventionellen und komplementären Therapien. Die vorliegende multizentrische Registerstudie untersuchte die Umsetzung von integrativen onkologischen Therapiekonzepten und der Assoziation mit dem Überleben von Patienten im fortgeschrittenen Stadium IV bei Bauchspeicheldrüsenkrebs unter Gabe von Mistelextrakten – mit positiven Effekten: Patienten mit kombinierter Chemo- und Misteltherapie zeigten einen statistisch signifikant besseren Überlebensvorteil als Patienten mit alleiniger Chemotherapie; Patienten, die nur eine Misteltherapie erhielten, zeigten statistisch signifikant längere Überlebensraten als jene, die weder Chemotherapie noch Misteltherapie erhielten.

Abstract

Integrative oncological therapy concepts are a combination of conventional and complementary therapies. The present multicenter register study examined the implementation of integrative oncological therapy concepts and the association with the survival of patients in the advanced stage IV in the case of pancreatic cancer when administering mistletoe extracts – with positive effects: patients with combined chemotherapy and mistletoe therapy showed a statistically significantly better survival benefit than patients with chemotherapy alone; patients receiving only a mistletoe therapy showed statistically significantly longer survival rates than those patients, receiving neither a chemotherapy nor a mistletoe therapy.

Schlüsselwörter

Misteltherapie - Mistelextrakt - Pankreaskarzinom - Komplementärmedizin - integrative Onkologie - anthroposophische Medizin

Key words

Mistletoe therapy - mistletoe extract - pancreatic carcinoma - complementary medicine - integrative oncology - anthroposophic medicine

• Literatur

• 1 Axtner J, Steele M, Kroz M. et al. Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer. BMC Cancer 2016; 16: 579
• 2 Bar-Sela G. White-Berry Mistletoe (Viscum album L.) as complementary treatment in cancer: Does it help?. European Journal of Integrative Medicine 2011; 3: e55-e62
• 3 Büssing A. Mistletoe. The Genus Viscum. Hardwood Academic, Amsterdam, the Netherlands: 2000
• 4 Hiripi E, Gondos A, Emrich K. et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012; 23: 472-9
• 5 Kaatsch P, Spix C, Hentschel S. et al. Krebs in Deutschland 2007/2008. Robert-Koch-Institut Berlin; 2012 86h ed
• 6 Kienle GS, Kiene H. Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 2010; 9: 142-57
• 7 Horneber MA, Bueschel G, Huber R. et al. Mistletoe therapy in oncology. Cochrane Database Syst Rev.. 2008 CD003297
• 8 Schad F, Axtner J, Happe A. et al. Network Oncology (NO) – a Clinical Cancer Register for Health Services Research and the Evaluation of Integrative Therapeutic Interventions in Anthroposophic Medicine. Forsch Komplementmed 2013; 20: 353-60
• 9 Seufferlein T, Bachet JB, Van Cutsem E. et al. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 (Suppl. 07) vii33-40
• 10 Troger W, Galun D, Reif M. et al. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer 2013; 49: 3788-97
• 11 Vincent A, Herman J, Schulick R. et al. Pancreatic cancer. Lancet 2011; 378: 607-20
• 12 Zaenker K. A Specific Mistletoe Preparation (Iscador-Qu^®) in Colorectal Cancer (CRC) Patients: More than Just Supportive Care?. Journal of Cancer Science & Therapy. 2012